Skip to main content
SpringerLink
Log in

Cancer Chemo- and Immunopharmacology

2: Immunopharmacology, Relations, and General Problems

  • Book
  • © 1980

Overview

Editors:
  1. Georges Mathé

    1. Institut de Cancérologie et Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Franco M. Muggia

    1. Division of Oncology, Department of Internal Medicine, Institute of Environmental Medicine, New York University Medical Center, New York, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 75)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 16.99 USD 84.99
Discount applied Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (40 chapters)

  1. Front Matter

    Pages I-XI
    Download chapter PDF

  2. Tumor-Specific Antigens

    • M. Pfreundschuh, H. Shiku, T. Takahashi, R. Ueda, J. Ransohoff, H. F. Oettgen et al.
    Pages 1-9

  3. Autoreactive Cells as Mediators of the Natural Defense Against Malignant Tumors

    • L. Olsson
    Pages 10-15

  4. Progress in Experimental Systemic Active Immunotherapy of Cancer

    • G. Mathé, I. Florentin, M. Bruley-Rosset, N. Kiger
    Pages 16-19

  5. Host’s Immune State and Kinetics of Local Tumor Growth Control — Progression of Postoperative Lung Metastasis

    • E. Gorelik, S. Segal, M. Feldman
    Pages 20-28

  6. Immunotherapy Versus Chemotherapy of Acute Myeloid Leukemia: Response to PHA, Allogeneic Lymphocytes, and Leukemic Myeloblasts of Remission Lymphocytes from Leukemia Patients

    • P. Reizenstein, C. Ogier, A.-M. Sjögren
    Pages 29-36

  7. Suppressor Cells in Hodgkin’s Disease and Lung Carcinoma

    • R. Huchet, Y. Thomas, D. Grandjon
    Pages 37-40

  8. Immune Imbalance in Cancer Patients

    • B. Serrou, L. Gauci, J. Caraux, D. Cupissol, C. Thierry, C. Esteve
    Pages 41-46

  9. Immunorestoration of Anergic Cancer Patients by Azimexon

    • A. Goutner, F. Nasrat, D. Bonardelle, G. Rameau
    Pages 47-52

  10. BCG Versus VCN: The Antigenicity and the Adjuvant Effect of Both Compounds

    • F. R. Seiler, H.-H. Sedlacek
    Pages 53-60

  11. Differences in Chemotherapeutic Susceptibility of Human T-, B-, and Non-T-/Non-B-Lymphocytes in Culture

    • T. Ohnuma, H. Arkin, J. F. Holland
    Pages 61-67

  12. The Significance of Lectin Receptors in the Kidney and in Hypernephroma (Renal Adenocarcinoma)

    • M. Vierbuchen, P. J. Klein, G. Uhlenbruck, H. O. Klein, H. E. Schaefer, R. Fischer
    Pages 68-75

  13. Specific Immunotherapy of Acute Lymphoid Leukemia Patients by REH Cell Line

    • C. Rosenfeld, M. C. Martyré, J. L. Pico, B. Serrou, M. Greaves
    Pages 76-79

  14. Results of Postoperative Treatment of Colorectal Cancer by Radiotherapy, Chemotherapy and Immunotherapy

    • E. Robinson, A. Bartal, T. Mekori
    Pages 80-87

  15. Some “Pharmacologic” Data About Corynebacterium Parvum

    • L. Israel
    Pages 88-91

  16. Increased Resistance to Tumor Graft in Mice Infected by Vaccinal Strains of Brucella Abortus

    • L. Dazord, Y. le Garrec, M. Bonnier, L. Toujas
    Pages 92-99

  17. Thymosin: Basic Properties and Clinical Application in the Treatment of Immunodeficiency Diseases and Cancer

    • G. D. Marshall Jr., G. B. Thurman, T. L. K. Low, A. L. Goldstein
    Pages 100-105

  18. One or Several Thymic Hormones?

    • J.-F. Bach
    Pages 106-109

  19. Ability of Thymosin to Decrease in Vivo and in Vitro Suppressor Cell Activity in Tumor Bearing Mice and Cancer Patients

    • B. Serrou, D. Cupissol, J. Caraux, C. Thierry, C. Rosenfeld, A. L. Goldstein
    Pages 110-114

  20. Screening of Small Molecular Microbial Products Modulating Immune Responses and Bestatin

    • H. Umezawa
    Pages 115-125
Back to top

Keywords

Editors and Affiliations

  • Institut de Cancérologie et Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    Georges Mathé

  • Division of Oncology, Department of Internal Medicine, Institute of Environmental Medicine, New York University Medical Center, New York, USA

    Franco M. Muggia

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation